Page last updated: 2024-10-30

mesalamine and Tuberculosis, Pulmonary

mesalamine has been researched along with Tuberculosis, Pulmonary in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.

Research Excerpts

ExcerptRelevanceReference
"Differentiating Crohn's disease (CD) from intestinal tuberculosis (TB) is a challenge."1.62Case of Crohn's Disease Initially Misdiagnosed as Intestinal Tuberculosis Due to Active Pulmonary Tuberculosis. ( Choi, S; Kim, D; Lee, T; Lim, W; Oh, H; Park, H; Park, S; Song, C; Yun, J, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Park, S2
Lee, T1
Lim, W1
Park, H1
Yun, J1
Kim, D1
Choi, S1
Oh, H1
Song, C1

Other Studies

1 other study available for mesalamine and Tuberculosis, Pulmonary

ArticleYear
Case of Crohn's Disease Initially Misdiagnosed as Intestinal Tuberculosis Due to Active Pulmonary Tuberculosis.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2021, 01-25, Volume: 77, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents; Antitubercular Agents; Colonoscopy; Crohn Disease; Diagnostic

2021